A STAT3 polymorphism can be used to predict the response to interferon-α in patients with metastatic renal cell cancer

Source: Inpharma, Volume 1, Number 1599, 2007-08-04 , pp. 15-15(1)

Publisher: Adis International

Keywords: Genetic-polymorphism; Interferon-alpha, therapeutic use; Renal-cancer, treatment

Document Type: Research article

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers